GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Tottenham Acquisition I Ltd (NAS:CLNN) » Definitions » Net Change in Cash

Tottenham Acquisition I (Tottenham Acquisition I) Net Change in Cash : $-0.01 Mil (TTM As of Sep. 2020)


View and export this data going back to 2018. Start your Free Trial

What is Tottenham Acquisition I Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Tottenham Acquisition I's Net Change in Cash for the three months ended in Sep. 2020 was $0.18 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Sep. 2020 was $-0.01 Mil.

Tottenham Acquisition I Net Change in Cash Historical Data

The historical data trend for Tottenham Acquisition I's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tottenham Acquisition I Net Change in Cash Chart

Tottenham Acquisition I Annual Data
Trend Dec17 Dec18 Dec19
Net Change in Cash
- 0.74 -0.31

Tottenham Acquisition I Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -0.09 -0.02 -0.10 -0.07 0.18

Tottenham Acquisition I Net Change in Cash Calculation

Tottenham Acquisition I's Net Change in Cash for the fiscal year that ended in Dec. 2019 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-0.597+0+0.283+0
=-0.31

Tottenham Acquisition I's Net Change in Cash for the quarter that ended in Sep. 2020

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-0.555+0+0.732+0
=0.18

Net Change in Cash for the trailing twelve months (TTM) ended in Sep. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tottenham Acquisition I Net Change in Cash Related Terms

Thank you for viewing the detailed overview of Tottenham Acquisition I's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Tottenham Acquisition I (Tottenham Acquisition I) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Tottenham Acquisition I Ltd (NAS:CLNN) » Definitions » Net Change in Cash
Comparable Companies
ELLH DEVV RLBY CCYC KBLM AVCT BRPA KXIN CPMD ECRD CCXX CCX FPAC VTIQ SPAQ FEAC CCH CPAA LSE:EVRA GHIV
Traded in Other Exchanges
N/A
Address
39-41 Wellington Street, Unit 902, Lucky Building, Central, Hong Kong, HKG
Website
Tottenham Acquisition I Ltd is a blank check company formed for the purpose of entering a merger, share exchange, asset acquisition, share purchase, recapitalization or similar business with one or more businesses or entities.

Tottenham Acquisition I (Tottenham Acquisition I) Headlines

From GuruFocus

Clene Awarded Grant From National Multiple Sclerosis Society to Advance Development of CNM-Au8� in Non-Active Progressive Multiple Sclerosis

By sperokesalga sperokesalga • 05-25-2023

Clene Announces Launch of Proposed Public Offering

By sperokesalga sperokesalga • 06-15-2023

Clene to Present at Upcoming September Investor Conferences

By Ds*** Ds*** • 08-30-2022

Clene Welcomes New Shareholder Base and Announces Closing of Underwritten Public Offering of $40 Million

By sperokesalga sperokesalga • 06-21-2023

VISIONARY-MS Trial Results Featured in Platform Presentation at PACTRIMS 2022: CNM-Au8� Demonstrated Global Neurological Improvement in Stable MS Patients as Adjunct to Background Disease Modifying Therapies

By Value_Insider Value_Insider • 11-28-2022

ALS and MS Clinical Data from Clene's CNM-Au8� Featured in Multiple Presentations at the 2023 American Academy of Neurology Annual Meeting

By sperokesalga sperokesalga • 04-25-2023

Clene Reports Significant Long-Term Survival Improvement From CNM-Au8 Treatment in HEALEY ALS Platform Trial Compared to PRO-ACT Historical Controls

By Marketwired • 09-25-2023

Clene Announces Updated VISIONARY-MS Phase 2 Trial Data Presented at 2023 ACTRIMS Forum Show CNM-Au8� Demonstrated Significant Improvements in Clinical Outcomes, Brain Structure, and Visual System

By sperokesalga sperokesalga • 02-27-2023

Clene to Participate in the Maxim Group Virtual Healthcare Conference

By sperokesalga sperokesalga • 06-15-2023

Clene Reports Second Quarter 2023 Financial Results and Operating Highlights

By Marketwired • 08-14-2023